Is the current anti-osteoporotic therapy paradigm good enough? [16]

Journal of the American Geriatrics Society

Volumn 54, Issue 12, 2006, Pages 1960-1961

  Fisher, Alexander A ^a   Davis, Michael W ^a  

^a The Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANABOLIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIFEDIOL; CALCIUM; CREATININE; HEMOGLOBIN; MAGNESIUM; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PHOSPHATE; RISEDRONIC ACID;

ADULT; AGED; BONE DENSITY; BONE TURNOVER; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG INDICATION; FEMALE; FRAGILITY FRACTURE; GERIATRIC PATIENT; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; QUALITY ADJUSTED LIFE YEAR; VITAMIN BLOOD LEVEL;

AGED; ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NURSING HOMES; OSTEOPOROSIS; PARATHYROID HORMONE; TERIPARATIDE;

EID: 33845478170     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2006.00978.x     Document Type: Letter

References (10)

1. Boonen S, Marin F, Mellstrom D et al. Safety and efficacy of teriparatide in elderly women with established osteoporosis: Bone anabolic therapy from a geriatric perspective. J Am Geriatr Soc 2006;54:782-789.
2. Agrawal S, Krueger DC, Engelke JA et al. Between-meal risedronate does not alter bone turnover in nursing home residents. J Am Geriatr Soc 2006;54:790-795.
3. Troen BR. Osteoporosis in older people. A tale of two studies (and three treatments). J Am Geriatr Soc 2006;54:853-855.
4. Hodsman AB, Bauer DC, Dempster DW et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use. Endocr Rev 2005;26:688-703.
5. Liu H, Michaud K, Nayak S et al. The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis. Arch Intern Med 2006;166:1209-1217.
6. Seeman E, Demas PD. Bone quality - the material and structural basis of bone strength and fragility. N Engl J Med 2006;25:2250-2261.
7. Eastell R, Barton I, Hannon RA et al. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res 2003;18:1051-1056.
8. Bauer DC, Garnero P, Bilezikian JP et al. Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 2006;91:1370-1375.
9. Sahota O, Mundey MK, San P et al. The relationship between vitamin D and parathyroid hormone: Calcium homeostasis, bone turnover and bone mineral density in postmenopausal women with established osteoporosis. Bone 2004;35:312-319.
10. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353-373.